Gold nanoparticles are especially appealing as OCT contrast agents because they are less toxic [
5], easier to synthesize, and more cost-effective [
6] compared with other molecular markers such as fluorescent molecules and quantum dots. Besides many other advantages, nanoparticles with small sizes (typically<100 nm) like gold nanorods (GNRs) with sharp spectral linewidths [
7] (the spectral response of gold nanoshells [
8] is too broad, full width at half maximum (FWHM)>200 nm) and small sizes (much smaller than some other nanoparticles, such as nanoshells [
8] or nanocages [
9], etc.) are more desirable for spectroscopic OCT (SOCT) [
10] as biomedical contrast agents. The longitudinal plasmon resonances of GNRs can be conveniently tuned (by adjusting their aspect ratio of length to diameter) to cover a large range from 525 to more than 1400 nm [
11,
12], which are excellent working wavelengths for OCT sources. Recently, GNRs have been developed as contrast agents for OCT [
13], and gold nanoparticles are detected by photothermal methods [
14,
15]. As contrast agents, however, most of these GNRs are of highly scattering type, and they are difficult to synthesize near infrared spectrum and must be used with a large dosage (to get a high enough contrast) in highly scattering medium like tissues. For smaller-size GNRs, absorption contributes much more to the extinction loss than scattering. For instance, the scattering magnitude is less than 10% of the absorption for GNRs with effective radius
reff =11.43 nm and various aspect ratios (length-to-diameter) [
16]. These high-absorption GNRs are about five times smaller (in volume) than highly scattering GNRs [
13] and more than 10 times smaller than gold nanoshells [
8]. Thus, they are easier to penetrate into tissues and greater dosages can be allowed (if needed) [
17] for
in vivo applications. These GNRs also have the potential for photothermal therapy [
18] due to their strong absorption. Primarily, the depth-dependent OCT signal is dictated by the tissue with optical backscattering and extinction coefficients. However, when these high-absorption GNRs are used to target molecular markers of interest, like some specific tumors, it is difficult to clearly discriminate them from the targeted part. To take advantage of the high absorption of GNRs, a fundamental question is how to retrieve the strong absorption information of GNRs. In this article, we use small-sized GNRs (effective radius <13 nm) as strong absorption contrast agents (instead of scattering contrast agents) to greatly enhance the contrast of OCT images. Furthermore, we introduce a mechanism called differential absorption OCT imaging, to retrieve the absorption information from conventional OCT signals.